Medscape

The Current Role of Circulating Tumor Cells in the Diagnosis and Management of Bone Metastases in Advanced Prostate Cancer

Prostate-specific antigen (PSA) has been used for over two decades as a serum marker for adenocarcinoma of the prostate. Although PSA screening remains an important part of disease screening and ...
Medscape

ESMO Revises Early Prostate Cancer Diagnosis and Monitoring

The European Society for Medical Oncology has updated its clinical practice guidelines for the management of localised prostate cancer and biochemical recurrence, refining diagnostic pathways and ...
Science Daily

MRI-first strategy for prostate cancer detection proves to be safe, study finds

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...
Purdue University

Improving prostate cancer relapse forecast by 14 months

WEST LAFAYETTE, Ind. — A new tool could help save lives by predicting prostate cancer relapse 14 months earlier than current standard methods. The tool, a computer model, makes its predictions by ...
ascopubs.org

Variations in PSMA PET utilization, PSA testing, and urologist involvement in advanced castrate resistant prostate cancer: Comparing academic and community practices in the US.

Impact of BRCA alterations on androgen receptor pathway inhibition treatment outcome in advanced prostate cancer. Predictive associations between serum dehydroepiandrosterone sulfate (DHEAS) and race ...